Otamixaban Uses, Dosage, Side Effects and more
Otamixaban is a novel direct Factor Xa (FXa) inhibitor. It is currently being developed by the French pharmaceutical company Sanofi-Aventis as a treatment for acute coronary syndrome.
| Trade Name | Otamixaban |
| Generic | Otamixaban |
| Otamixaban Other Names | Otamixaban |
| Type | |
| Formula | C25H26N4O4 |
| Weight | Average: 446.4983 Monoisotopic: 446.19540534 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in thrombosis.
Food Interaction
- Avoid herbs and supplements with anticoagulant/antiplatelet activity. Examples include garlic, ginger, bilberry, danshen, piracetam, and ginkgo biloba.
